Ripple kopen? Dit zijn de mogelijkheden

Medtronic Aandeel

108,51USD 0,01USD 0,01%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Medtronic PLC - Profiel

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Aandeelhouder

Eigenaar in %
The Vanguard Group, Inc.8,19
Wellington Management Co. LLP5,10
BlackRock Fund Advisors4,96
SSgA Funds Management, Inc.4,30
Massachusetts Financial Services Co.4,25
Lazard Asset Management LLC2,08
T. Rowe Price Associates, Inc. (Investment Management)1,62
Geode Capital Management LLC1,31
Northern Trust Investments, Inc.(Investment Management)1,25
Franklin Mutual Advisers LLC1,16
Barrow, Hanley, Mewhinney & Strauss LLC1,08
UBS Financial Services, Inc.1,05
Norges Bank Investment Management0,92
Columbia Management Investment Advisers LLC0,91
Artisan Partners LP0,90

Adres

20 On Hatch, 2 Dublin
Postbus:
Telefoon: 35314381700
Fax:
Internet: http://www.medtronic.com

Management

Omar S. Ishrak, PhD
Chairman & Chief Executive Officer
Karen L. Parkhill, MBA
Chief Financial & Accounting Officer, Executive VP
Carol A. Surface, PhD
Chief Human Resources Officer & Senior VP
Luann M. Pendy
Chief Quality & Regulatory Affairs Officer, SVP
Richard E. Kuntz, MD
Chief Scientific, Clinical & Regulatory Officer
Robert White
EVP & President-Minimally Invasive Therapies
Geoffrey Straub Martha
Executive VP & President-Restorative Therapies
Michael J. Coyle, MBA
Group President-Cardiac & Vascular Group
Craig Arnold, MBA
Independent Director
Denise M. O'Leary, MBA
Independent Director
Michael O. Leavitt
Independent Director
Randall J. Hogan III, MBA
Independent Director
James T. Lenehan, MBA
Independent Director
Kendall J. Powell, MBA
Independent Director
Richard H. Anderson
Independent Director
Elizabeth G. Nabel, MD
Independent Director
Andrea J. Goldsmith, PhD
Independent Director
Scott C. Donnelly
Lead Independent Director
Robert J. W. ten Hoedt
President-Europe, Middle East & Africa Region
Bradley E. Lerman
Secretary, Senior Vice President & General Counsel
Scott Lee, MD
Senior Medical Director
Mark Ploof
Senior VP-Global Operations & Business Services
Alex Gu
Senior Vice President
Chris Lee
Senior Vice President & President-Asia Pacific
Michael Weinstein
Senior Vice President-Strategy
Sheri Dodd
VP & GM-Medtronic Care Management Services
Alejandro Galindo
VP & President-Intensive Insulin Management
Laura Mauri
Vice President
Francesca M. DeMartino
Vice President-Corporate Communications
Ryan Weispfenning
Vice President-Investor Relations

Invoer toevoegen